Akers Board Rearrangement THOROFARE, NJ--(Marketwired -

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Akers Board Rearrangement

THOROFARE, NJ--(Marketwired - Apr 29, 2016) - Akers Biosciences, Inc. ( NASDAQ : AKER ) ( AIM : AKR.L ), ("Akers Bio" or the "Company"), a developer of rapid health information technologies, announces changes to the roles of certain board members, which take effect immediately and are designed to improve the effectiveness of the Board of Directors.

Thomas Knox, currently Non-executive Co-Chairman, becomes the Company's sole chairman. Mr. Knox is a Philadelphia-based businessman with high level corporate and governance experience. Mr. Knox has owned, managed, and sold multiple profitable companies in the software, banking, and health insurance industries including Disc Systems, Inc., Crusader Bank, Gimco International, Kasser Industries and Fidelity Insurance Group. He also served as Chief Executive Officer for United HealthCare of Pennsylvania and served as Special Deputy Rehabilitator & Chief Executive Officer of Fidelity Mutual Life Insurance Co., Pennsylvania's 5th largest insurer. He was candidate for Mayor of Philadelphia in 2007 and candidate for Governor of Pennsylvania in 2010.

Raymond F. Akers, Jr. PhD, currently Co-founder and Executive Chairman, becomes Co-founder and Chief Scientific Director. Dr. Akers invented the Company's platform technologies on which its products are based, including Particle ImmunoFiltration Assay (PIFA), and will continue to lead the scientific development of Akers Bio's product pipeline and the scientific enhancements of the Company's commercialized products. Dr. Akers remains a director of the Company and, as Co-founder, will continue to interface with shareholders.

Thomas Knox, Chairman, commented:

"Having our recently appointed CEO focusing successfully on product commercialization and operations enables us to deploy the strengths of the Board of Directors more effectively; I am pleased that this allows Dr. Akers to focus on accelerating the development of our pipeline of rapid diagnostic tests."

Raymond F. Akers, Jr., Co-founder, commented:

"This new delegation of responsibilities is good for the Company. I can more effectively utilize my technical strengths and advance the Company to the next level of scientific excellence, particularly in the fields of health and wellness, and infectious and respiratory diseases, which are potentially huge markets in which rapid diagnostic technology can dramatically improve the quality of care. I look forward to continuing to communicate the Akers Bio story to the investment community."

About Akers Biosciences, Inc.

Akers Biosciences develops, manufactures, and supplies rapid screening and testing products designed to deliver quicker and more cost-effective healthcare information to healthcare providers and consumers. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The Company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. The Company has aligned with major healthcare companies and high volume medical product distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics.

Additional information on the Company and its products can be found at www.akersbio.com . Follow us on Twitter @AkersBio .

Cautionary Statement Regarding Forward Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Akers Biosciences, Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

For more information: Akers Biosciences, Inc. Raymond F. Akers, Jr. PhD Executive Chairman Tel. +1 856 848 8698 Taglich Brothers, Inc. (Investor Relations ) Chris Schreiber Tel. +1 917 445 6207 Email: cs@taglichbrothers.com finnCap (UK Nominated Adviser and Broker) Adrian Hargrave / Scott Mathieson (Corporate Finance) Steve Norcross (Broking) Tel. +44 (0)20 7220 0500 Vigo Communications (Public Relations) Ben Simons / Fiona Henson Tel. +44 (0)20 7830 9700 Email: akers@vigocomms.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Elah Holdings' Q3 2026 Report Sparks Investor Interest

Updated Category News Views 79

Elah Holdings Drops Their Q3 2026 Numbers Eat your heart out, folks—Elah Holdings has just dropped their third quarter report for 2026, and it caught some eyes. This ain't your run-of-the-mill, brush-right-past-it release. They're out there, waving their flag high in the competitive marketplace, trying to tell us they mean business. If you missed the announcement, they...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 137

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 171

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading
Texxon Faces Revenue Slide Amid Strategic Shifts

Updated Category News Views 155

Texxon's Strategic Transitions and Financial Headaches Texxon Holding Limited (NASDAQ:NPT) just laid their cards on the table, unveiling a mixed bag in their fiscal year 2026 results. As the world's chemical and plastics scene faces winds of change, Texxon buckled down and tried to steer the ship clear from the rocks. It's a balancing act juggling market headwinds, a new...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 359

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 139

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading
The Melt Grabs Top Spot in Burger Ratings War

Updated Category News Views 122

Burger Battle: The Melt Claims Victory When you're in the cutthroat world of fast-casual dining, grabbing the top spot on any list is no small potatoes. The Melt did just that, snatching the title of America’s Highest-Rated Burger Spot. Based on an in-depth analysis of Google and Yelp reviews, folks have spoken, loud and clear, over the past two years. It's a world...

Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 0

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 0

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading

Top 5 Most Recently Viewed Articles

Síminn hf. Achieves Strong Growth in Q2 2025 Results

Updated Category News Views 303

Exciting Financial Highlights from Síminn hf. for Q2 2025 In the second quarter of 2025, Síminn hf. reported remarkable financial growth, demonstrating their resilient operations and commitment to enhancing customer value. The total revenue surged to ISK 7,196 million, marking a 4.7% increase compared to Q2 2024, where revenues stood at ISK 6,871 million. This positive...

Continue Reading
Pacesetter Joins Inc.'s 2026 Best Workplaces List

Updated Category News Views 33

Pacesetter Technology Earns a Spot on Inc.'s Renowned List How many times have we heard companies rattle on about employee satisfaction and culture? But this time, we're talking about a company, Pacesetter Technology, that didn't just talk the talk—they walked right into Inc.'s 2026 Best Workplaces spotlight. And in an era where employers hold all the cards, that's no...

Continue Reading
Discover Meiyume's Innovative Beauty Solutions at Cosmopack

Updated Category News Views 272

Unveiling Meiyume at Cosmopack Asia 2025 Hong Kong, leading the way in beauty solutions, is set to host an influential event as Meiyume showcases its innovative initiative titled SEEDED — Rooted in Intelligence, Connected Through the Beauty Vein at Cosmopack Asia. With a strong foothold in packaging and product development, Meiyume leverages its proprietary Beauty...

Continue Reading
MAHA Action, Inc. Announces Support for Zach Lahn's Governor Bid

Updated Category News Views 215

MAHA Action, Inc. Endorses Zach Lahn for Iowa Governor MAHA™ Action, Inc., a prominent advocate for health freedom, proudly announces its endorsement of Zach Lahn as the next Governor of Iowa. Lahn has launched an Iowa First platform aimed at empowering residents and improving personal liberties. Commitment to Health Freedom Lahn has emerged as a vigorous champion of...

Continue Reading
Couchbase Reports Impressive Q1 Earnings Amid Rising Demand

Updated Category News Views 309

Financial Performance Highlights for Couchbase Couchbase, Inc. (NASDAQ: BASE), the leading developer data platform that powers critical applications in today’s AI-driven world, has unveiled its financial performance for the first quarter ended April 30, 2025. With a remarkable increase in revenue and strong annual recurring revenue (ARR), Couchbase has demonstrated the...

Continue Reading